In Ewing family tumors, elevated STEAP1 expression correlates with diminished metastasis-free survival (MFS), defined as the interval from treatment initiation to the first occurrence of localized lymph node or distant organ metastasis. This evidence concerns the gene STEAP1 and Ewing sarcoma/peripheral primitive neuroectodermal tumor.